# Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders

> **NCT02586935** · PHASE2 · COMPLETED · sponsor: **Holland Bloorview Kids Rehabilitation Hospital** · enrollment: 83 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Tideglusib
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02586935
- **Lead sponsor:** Holland Bloorview Kids Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-10
- **Primary completion:** 2018-02-25
- **Final completion:** 2018-02-25
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586935, "Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02586935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*